» Authors » Christoforos Kosmidis

Christoforos Kosmidis

Explore the profile of Christoforos Kosmidis including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 112
Citations 499
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Zarogoulidis P, Papadopoulos V, Perdikouri E, Vagionas A, Matthaios D, Oikonomidou R, et al.
Lung Cancer Manag . 2025 Jan; :2370227. PMID: 39883099
Lung cancer is still diagnosed at an advanced stage due to lack of early disease symptoms. We have techniques and equipment for rapid on site evaluation of pulmonary lesions. However,...
2.
Moysidis M, Chorti A, Cheva A, Abba Deka I, Tzikos G, Kosmidis C, et al.
Pharmaceuticals (Basel) . 2024 Nov; 17(11). PMID: 39598326
Introduction: The utilization of probiotics in enhancing the active healing of skin wounds represents a burgeoning trend in contemporary medicine. Previous research has extensively explored wound healing mechanisms involving the...
3.
Kosmidis C, Boulogeorgou K, Roulia P, Dagher M, Anthimidis G, Petrakis G, et al.
Diagnostics (Basel) . 2024 Jun; 14(11). PMID: 38893658
Breast cancer is the most common type of cancer of the female gender. A rare subtype of breast cancer is the invasive breast carcinoma (IBC) with neuroendocrine (NE) differentiation. Its...
4.
Katopodi T, Petanidis S, Floros G, Porpodis K, Kosmidis C
Cells . 2024 Jun; 13(11. PMID: 38891040
The future of drug delivery offers immense potential for the creation of nanoplatforms based on nanogels. Nanogels present a significant possibility for pharmaceutical advancements because of their excellent stability and...
5.
Katopodi T, Petanidis S, Grigoriadou E, Anestakis D, Charalampidis C, Chatziprodromidou I, et al.
Pharmaceutics . 2024 Apr; 16(4). PMID: 38675116
Extensive research into mRNA vaccines for cancer therapy in preclinical and clinical trials has prepared the ground for the quick development of immune-specific mRNA vaccines during the COVID-19 pandemic. Therapeutic...
6.
Laskou S, Kountouri I, Paschou E, Topalidis C, Axi P, Petrakis G, et al.
Clin Case Rep . 2024 Apr; 12(4):e8753. PMID: 38617065
Atypical parathyroid tumors represent a group of parathyroid neoplasms of uncertain malignant potential. In view of preoperative diagnostic difficulties, suspicious features for malignancy may guide the surgeon to perform a...
7.
Mantalovas S, Paschou E, Kountouri I, Sevva C, Papadopoulos K, Roulia P, et al.
Diagnostics (Basel) . 2024 Mar; 14(5). PMID: 38473027
A 40-year-old female patient presented to a secondary facility with dull lower abdominal pain and a persistent low-grade fever. Her laboratory results showed elevated inflammation markers. A CT scan revealed...
8.
Katopodi T, Petanidis S, Anestakis D, Charalampidis C, Chatziprodromidou I, Floros G, et al.
Front Immunol . 2024 Jan; 14:1325360. PMID: 38292487
A significant factor in the antitumor immune response is the increased metabolic reprogramming of immunological and malignant cells. Increasing data points to the fact that cancer metabolism affects not just...
9.
Zarogoulidis P, Petridis D, Huang H, Bai C, Pitsiou G, Matthaios D, et al.
J Cancer . 2024 Jan; 15(4):871-879. PMID: 38230210
Pulmonary hypertension is common symptom among several diseases. The consequences are severe for several organs. Pulmonary hypertension is usually under-diagnosed and the main symptom observed is dyspnea with or without...
10.
Zarogoulidis P, Papadopoulos V, Perdikouri E, Vagionas A, Matthaios D, Ioannidis A, et al.
J Cancer . 2024 Jan; 15(4):880-888. PMID: 38230209
Single pulmonary nodules are a difficult to diagnose imagining artifact. Currently novel diagnostic tools such as Radial-EBUS with or not C-ARM flouroscopy, electromagnetic navigation systems, robotic bronchoscopy and cone beam-compuer...